Published by Coherent Market Insights
Posted on September 30, 2021
5 min readLast updated: February 1, 2026
The CGM market is expanding due to innovative devices and rising diabetes cases, with strong growth in North America.
Continuous Glucose Monitoring is an innovative non-intrusive method to measure long-term blood glucose control. The CGM instrument, an infrared sensor is attached to the fingertip of the individual taking the test. A small blood sample is first taken with a disposable applicator and then sent for analysis to a laboratory. A highly sensitive test known as quantitative blood testing (or QFT) is performed on the collected blood samples. A specific protocol for interpreting the results of the test is followed by the physician based on his findings. Continuous glucose monitoring device provides the doctor with important information about the condition of the patient. This is important because the doctor needs to make treatment decisions based on the observations of the patient.
Get a Sample Copy of the Continuous Glucose Monitoring (CGM) Devices market Report 2021 @
https://www.coherentmarketinsights.com/insight/request-sample/57
Major Market Players Profiled in the Continuous Glucose Monitoring (CGM) Devices Market Report include: Medtronic, Dexcom, Inc., Abbott Laboratories, Medtrum Technologies, Inc., Tandem Diabetes Care, Senseonics, Glycens, Insulet Corporation, and Nemaura Medical, Inc., STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc. and Micron Technology Inc.
The growing prevalence of diabetes is augmenting growth of the continuous glucose monitoring market. According to the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Of the 34.2 million adults with diabetes, 26.8 million were diagnosed, and 7.3 million were undiagnosed.
Continuous launch of new and advanced products is uplifting growth of the market. For instance, in March 2021, Roche has announced the launch of the new Accu-Chek Instant system, a new “connected” blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalized Diabetes Management (iPDM).
Covid-19 Impact Analysis
With continuing spread of coronavirus infection, MedTech companies are slowly and gradually building their recessionary curve by leveraging technology. Various organizations are going through response, renewal, and recovery phases. Continuous launch of the product by organizations to retain their position in the market will helps key players to get out of the COVID-19 pandemic.
Key Takeaways:
The continuous glucose monitoring market is expected to exhibit a CAGR of XX % over the forecast period, owing to the increasing research & development activities in the field. For instance, in June 2021, Researchers tested the effectiveness of the two different monitoring devices in 175 participants with type 2 diabetes who were being treated with insulin. They observed that people with type 2 diabetes who use insulin may see more benefits from the device than from a traditional blood glucose monitor, for which they periodically prick their skin to test their blood sugar.
North America is expected to gain significant growth over the forecast period and this is attributed to the presence of strong players in the region. For instance, Medtronic, Abbott Laboratories, GE Healthcare, and Texas Instruments Inc. are some of the key players in the United States.
Ask for PDF sample copy of the Continuous Glucose Monitoring (CGM) Devices market report @
https://www.coherentmarketinsights.com/insight/request-pdf/57
Reasons to purchase this research report:
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/57
Some Questions Answered in this Report:
• What are the winning strategies of stakeholders in the Continuous Glucose Monitoring (CGM) Devices market to upscale their position in this landscape?
• Which companies are leading the Continuous Glucose Monitoring (CGM) Devices market?
• Which regions will continue to remain the most profitable regional markets for Continuous Glucose Monitoring (CGM) Devices market players?
• Which factors will induce a change in the demand for Continuous Glucose Monitoring (CGM) Devices during the assessment period?
• How will changing trends impact the Continuous Glucose Monitoring (CGM) Devices market?
• How can market players capture the low-hanging opportunities in the Continuous Glucose Monitoring (CGM) Devices market in developed regions?
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Continuous Glucose Monitoring (CGM) Devices Market – Higher convenience offered by the CGM devices by manufacturers is expected to boost the growth of the market appeared first on Gatorledger.
The article focuses on the growth and trends in the Continuous Glucose Monitoring (CGM) devices market.
CGM devices provide non-intrusive, continuous monitoring, aiding in better diabetes management.
COVID-19 prompted MedTech companies to innovate and adapt, influencing market dynamics.
Explore more articles in the Research Reports category
